GSTP1 and chronic myelogenous leukemia, BCR-ABL1 positive: No significant difference was found between patients and the control and the study also revealed no association between GSTP1 Ile 105 Val polymorphism and the risk of developing CML:(OR=1.992, 95% CI: 0.396-9.322; p-value = 0.417).